A major breakthrough in photodynamic therapy

Recently, Guilin Xingda Photoelectric Medical Devices Co., Ltd. has developed a new generation of semiconductor laser photodynamic therapy instrument. With the approval of the State Food and Drug Administration, it has obtained registration certificates for three types of medical devices. Filling the gap of medical photodynamic therapy in high-end areas in China is a major breakthrough of independent innovation in the domestic medical industry.

Guilin Xingda Optoelectronic Medical Devices Co., Ltd. was established in 1998, and is a national award-winning enterprise for key new products. It focuses on the research, development and production of laser and ultrasound medical equipment, and has more than ten patents for inventions and practical new models. In 2004, the company developed the world-class semiconductor laser equipment PDT, which has been rapidly applied in more than 500 large medical institutions in the country. The company's laser and supporting optical fibers have independent intellectual property rights. Patented technology from laser packaging to assembly core is also the only cleaner production workshop of optical fibers in the world. Its optical fibers supply is also patented technology products. The whole equipment and consumables have passed the electromagnetic compatibility certification test, and also passed the international CE certification. With the large-scale promotion and application of therapeutic instruments at home and abroad, it will provide more abundant, more effective and safer treatment for medical units at all levels.

In recent years, Guilin National High-tech Industrial Development Zone has implemented the "3 + 3" industrial development strategy, developing and expanding the "three emerging" industries of electronic information, biomedicine and modern service industry, as well as the "three emerging" industries. "New materials, new energy industries, expanding the economy, accelerating industrial upgrading, to complete the beautiful and happy New Lijiang River in Guilin to provide solid economic support. It is reported that nearly 10 enterprises above the scale of Biopharmaceutical Enterprises in Guilin High-tech Zone, 28 Enterprises with an annual output value of more than 5 million yuan, modern Chinese medicine, special chemicals, plant extracts and preparations are newly added in three countries, and the biopharmaceutical industry accounts for 20% of the total output value of the scale industry in Guilin High-tech Zone.